• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LU Xiaolin, ZHENG Ying, QIU Yang, ZHOU Xiang, LU Tao. Small conjugate-based theranostic agents:a tumour microenvironment responsive approach for cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(6): 629-638. DOI: 10.11665/j.issn.1000-5048.20160601
Citation: LU Xiaolin, ZHENG Ying, QIU Yang, ZHOU Xiang, LU Tao. Small conjugate-based theranostic agents:a tumour microenvironment responsive approach for cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(6): 629-638. DOI: 10.11665/j.issn.1000-5048.20160601
shu

Small conjugate-based theranostic agents:a tumour microenvironment responsive approach for cancer therapy

More Information
    Graphical Abstract
    • Abstract
  • Theranostics, combining therapy and diagnosis, is an appealing approach for chemotherapy in medicine which exhibits improved biodistribution, selective cancer targeting ability, reduced toxicity, masked drug efficacy, and minimum side effects. The role of diagnosis tools in theranostics is to collect the information of the disease state before and after specific treatment. Currently, small conjugate-based systems have received much attention for cancer treatment and diagnosis. Relative to the normal tissues, tumor microenvironment shows great difference, including acidic excessive expression of various enzymes as well as low oxygen. In this review, the latest developments on small conjugate based theranostic agents for tumor treatment and diagnosis using fluorescence were summarized.
    • FullText(HTML)
    • References (29)
  • [1]
    Xie J,Lee S,Chen XY.Nanoparticle-based theranostic agents[J].Adv Drug Deliv Rev,2010,62(11):1064-1079.
    [2]
    Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy[J].Bioconjug Chem, 2011,22(10):1879-1903.
    [3]
    Nie S,Xing Y,Kim GJ,et al.Nanotechnology applications in cancer[J].Annu Rev Biomed Eng,2007,9(8):257-288.
    [4]
    Lim EK, Kim T, Paik S, et al. Nanomaterials for theranostics:recent advances and future challenges[J].Chem Rev,2015,115(1):327-394.
    [5]
    Jokerst JV,Gambhir SS.Molecular imaging with theranostic nanoparticles[J].Acc Chem Res,2011,44(10):1050-1060.
    [6]
    Dong X,Gu YQ.Application of optical molecular imaging technology in the diagnosis and treatment of diseases[J].J China Pharm Univ(中国药科大学学报),2014,45(2):145-152.
    [7]
    Zhou LZ,Wu XR,Chen L.Pharmacokinetics of magnetic nanoparticles as drug carrier and their applications in cancer diagnosis and therapy[J].J China Pharm Univ(中国药科大学学报),2003,34(3):279-282.
    [8]
    Sies H.Glutathione and its role in cellular functions[J].Free Radic Biol Med,1999,27(9/10):916-921.
    [9]
    Gregory RJ,Kirsten MT,McEwan J,et al.Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours[J].J Inorg Biochem,2004,98(10):1625-1633.
    [10]
    Santra S,Kaittanis C,Santiesteban OJ,et al.Cell-specific,activatable,and theranostic prodrug for dual-targeted cancer imaging and therapy[J].J Am Chem Soc,2011,133(41):16680-16688.
    [11]
    Yang Z,Lee JH,Jeon HM,et al.Folate-based near-infrared fluorescent theranostic gemcitabine delivery[J].J Am Chem Soc,2013,135(31):11657-11662.
    [12]
    Bildstein L,Dubernet C,Couvreur P.Prodrug-based intracellular delivery of anticancer agents[J].Adv Drug Deliv Rev,2011,63(1/2):3-23.
    [13]
    Maiti S,Park N,Han JH,et al.Gemcitabine-coumarin-biotin conjugates:a target specific theranostic anticancer prodrug[J].J Am Chem Soc,2013,135(11):4567-4572.
    [14]
    Bhuniya S,Lee MH,Jeon HM,et al.A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells[J].Chem Commun,2013,49(64):7141-7143.
    [15]
    Kim T,Jeon HM,Le HT,et al.A biotin-guided fluorescent-peptide drug delivery system for cancer treatment[J].Chem Commun,2014,50(57):7690-7693.
    [16]
    Bhuniya S,Maiti S,Kim EJ,et al.An activatable theranostic for targeted cancer therapy and imaging[J].Angew Chem Int Ed,2014,53(17):4469-4474.
    [17]
    Vineberg JG,Zuniga ES,Kamath A,et al.Design,synthesis,and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy[J].J Med Chem,2014,57(13):5777-5791.
    [18]
    Vineberg JG, Wang T, Zuniga ES, et al. Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugates[J].J Med Chem,2015,58(5):2406-2416.
    [19]
    Lee MH,Kim JY,Han JH,et al.Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug[J].J Am Chem Soc,2012,134(30):12668-12674.
    [20]
    Dongbang S,Jeon HM,Lee MH,et al.Camptothecin delivery into hepatoma cell line by galactose-appended fluorescent drug deli-very system[J].RSC Adv,2014,4:18744-18748.
    [21]
    Wu X,Sun X,Guo Z,et al.In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug[J].J Am Chem Soc,2014,136(9):3579-3588.
    [22]
    Wu J,Huang R,Wang CC,et al.Thiol-inducible direct fluorescence monitoring of drug release[J].Org Biomol Chem,2013,11:580-585.
    [23]
    Dickinson BC,Chang CJ.Chemistry and biology of reactive oxygen species in signaling or stress responses[J].Nat Chem Biol,2011,7(8):504-511.
    [24]
    Lippert AR,Van de Bittner GC,Chang CJ.Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems[J].Acc Chem Res,2011,44(9):793-804.
    [25]
    Kim EJ,Bhuniya S,Lee H,et al.An activatable prodrug for the treatment of metastatic tumors[J].J Am Chem Soc,2014,136(39):13888-13894.
    [26]
    Kumar R,Han J,Lim HJ,et al.Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug:in vivo imaging and precise cancer treatment[J].J Am Chem Soc,2014,136(51):17836-17843.
    [27]
    Manchun S,Dass CR,Sriamornsak P.Targeted therapy for cancer using pH- responsive nanocarrier systems[J].Life Sci,2012,90(11/12):381-387.
    [28]
    Song QL,Li P.Research progress of pH-sensitive material in pharmaceutical preparation[J].China J Hosp Pharm(中国医院药学杂志),2011,31:240-243.
    [29]
    Li SY,Liu LH,Jia HZ,et al.A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy[J].Chem Commun,2014,50(80):11852-11855.
    • Related Articles

  • Related Articles

    [1]ZHAO Xiaomei, WANG Xin, JI Xia, Zhang Jing, ZHANG Hua, HU Guoqiang. Synthesis and antitumor activity of heteroatom-substituted azulenes derivatives of 1,2-benzothiazine[J]. Journal of China Pharmaceutical University, 2024, 55(5): 634-638. DOI: 10.11665/j.issn.1000-5048.2023120503
    [2]SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405
    [3]LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
    [4]QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305
    [5]MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]CHENG Keguang, CHU Xiangwu, LIU Guanyan, SU Chunhua, DENG Shengping, PAN Hongmei. Synthesis and antitumor activities of 3-substituted estradiol-pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 26-32. DOI: 10.11665/j.issn.1000-5048.20140104
    [8]LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605
    [9]HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119.
    [10]ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498.

Catalog

    Get Citation
    PDF
    XML
    Article views (893) PDF downloads (2501) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366189

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return